nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—SLC22A1—Lamivudine—hepatitis B	0.275	0.765	CbGbCtD
Midazolam—ABCB1—Lamivudine—hepatitis B	0.0843	0.234	CbGbCtD
Midazolam—Fracture—Adefovir Dipivoxil—hepatitis B	0.0234	0.0487	CcSEcCtD
Midazolam—Multiple fractures—Adefovir Dipivoxil—hepatitis B	0.0234	0.0487	CcSEcCtD
Midazolam—Rhinorrhoea—Telbivudine—hepatitis B	0.0141	0.0294	CcSEcCtD
Midazolam—Tenderness—Telbivudine—hepatitis B	0.0131	0.0273	CcSEcCtD
Midazolam—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.0128	0.0265	CcSEcCtD
Midazolam—UGT1A4—Nicotine Metabolism—CYP2A6—hepatitis B	0.0126	0.0883	CbGpPWpGaD
Midazolam—Anaphylactoid reaction—Entecavir—hepatitis B	0.0105	0.0217	CcSEcCtD
Midazolam—Hypoxia—Lamivudine—hepatitis B	0.0102	0.0211	CcSEcCtD
Midazolam—Rhinorrhoea—Lamivudine—hepatitis B	0.00796	0.0166	CcSEcCtD
Midazolam—Dysphonia—Lamivudine—hepatitis B	0.00784	0.0163	CcSEcCtD
Midazolam—Nasopharyngitis—Telbivudine—hepatitis B	0.00743	0.0155	CcSEcCtD
Midazolam—Muscular weakness—Telbivudine—hepatitis B	0.00733	0.0152	CcSEcCtD
Midazolam—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00671	0.014	CcSEcCtD
Midazolam—Muscle twitching—Lamivudine—hepatitis B	0.00657	0.0137	CcSEcCtD
Midazolam—Immune system disorder—Entecavir—hepatitis B	0.00632	0.0131	CcSEcCtD
Midazolam—Neuropathy peripheral—Telbivudine—hepatitis B	0.00628	0.0131	CcSEcCtD
Midazolam—Wheezing—Lamivudine—hepatitis B	0.00627	0.013	CcSEcCtD
Midazolam—Mental disorder—Entecavir—hepatitis B	0.00613	0.0128	CcSEcCtD
Midazolam—CYP4B1—Synthesis of Leukotrienes (LT) and Eoxins (EX)—GGT1—hepatitis B	0.00578	0.0404	CbGpPWpGaD
Midazolam—Connective tissue disorder—Telbivudine—hepatitis B	0.00565	0.0117	CcSEcCtD
Midazolam—Phlebitis—Lamivudine—hepatitis B	0.00544	0.0113	CcSEcCtD
Midazolam—Sleep disorder—Lamivudine—hepatitis B	0.00541	0.0113	CcSEcCtD
Midazolam—Cough—Adefovir Dipivoxil—hepatitis B	0.00519	0.0108	CcSEcCtD
Midazolam—Mediastinal disorder—Telbivudine—hepatitis B	0.00518	0.0108	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00515	0.0107	CcSEcCtD
Midazolam—Injury—Lamivudine—hepatitis B	0.0051	0.0106	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00503	0.0105	CcSEcCtD
Midazolam—Anaphylactic shock—Entecavir—hepatitis B	0.00497	0.0103	CcSEcCtD
Midazolam—Nervous system disorder—Entecavir—hepatitis B	0.00488	0.0101	CcSEcCtD
Midazolam—Skin disorder—Entecavir—hepatitis B	0.00483	0.01	CcSEcCtD
Midazolam—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00476	0.00989	CcSEcCtD
Midazolam—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00471	0.0098	CcSEcCtD
Midazolam—UGT1A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00463	0.0324	CbGpPWpGaD
Midazolam—Affect lability—Lamivudine—hepatitis B	0.00461	0.00959	CcSEcCtD
Midazolam—CYP2B6—Nicotine Metabolism—CYP2A6—hepatitis B	0.00451	0.0315	CbGpPWpGaD
Midazolam—Mood swings—Lamivudine—hepatitis B	0.00444	0.00923	CcSEcCtD
Midazolam—Somnolence—Entecavir—hepatitis B	0.00442	0.00919	CcSEcCtD
Midazolam—Dyspepsia—Entecavir—hepatitis B	0.00438	0.0091	CcSEcCtD
Midazolam—Cough—Telbivudine—hepatitis B	0.00437	0.00908	CcSEcCtD
Midazolam—Gastrointestinal disorder—Entecavir—hepatitis B	0.00429	0.00893	CcSEcCtD
Midazolam—Fatigue—Entecavir—hepatitis B	0.00429	0.00891	CcSEcCtD
Midazolam—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00427	0.00888	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00423	0.0088	CcSEcCtD
Midazolam—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00419	0.00871	CcSEcCtD
Midazolam—Nasopharyngitis—Lamivudine—hepatitis B	0.00419	0.00871	CcSEcCtD
Midazolam—Muscular weakness—Lamivudine—hepatitis B	0.00413	0.00859	CcSEcCtD
Midazolam—Nervous system disorder—Telbivudine—hepatitis B	0.00401	0.00833	CcSEcCtD
Midazolam—Skin disorder—Telbivudine—hepatitis B	0.00397	0.00825	CcSEcCtD
Midazolam—Paraesthesia—Telbivudine—hepatitis B	0.00367	0.00763	CcSEcCtD
Midazolam—Depression—Lamivudine—hepatitis B	0.0036	0.00748	CcSEcCtD
Midazolam—Dyspepsia—Telbivudine—hepatitis B	0.0036	0.00748	CcSEcCtD
Midazolam—Asthenia—Entecavir—hepatitis B	0.00357	0.00742	CcSEcCtD
Midazolam—Neuropathy peripheral—Lamivudine—hepatitis B	0.00354	0.00736	CcSEcCtD
Midazolam—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00353	0.00733	CcSEcCtD
Midazolam—Fatigue—Telbivudine—hepatitis B	0.00352	0.00732	CcSEcCtD
Midazolam—Pain—Telbivudine—hepatitis B	0.00349	0.00726	CcSEcCtD
Midazolam—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00348	0.00724	CcSEcCtD
Midazolam—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00343	0.00714	CcSEcCtD
Midazolam—Feeling abnormal—Telbivudine—hepatitis B	0.00337	0.007	CcSEcCtD
Midazolam—UGT1A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00331	0.0231	CbGpPWpGaD
Midazolam—Dizziness—Entecavir—hepatitis B	0.00329	0.00684	CcSEcCtD
Midazolam—CYP4B1—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.0032	0.0224	CbGpPWpGaD
Midazolam—Connective tissue disorder—Lamivudine—hepatitis B	0.00318	0.00662	CcSEcCtD
Midazolam—Vomiting—Entecavir—hepatitis B	0.00316	0.00657	CcSEcCtD
Midazolam—CYP4B1—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00316	0.0221	CbGpPWpGaD
Midazolam—Rash—Entecavir—hepatitis B	0.00313	0.00652	CcSEcCtD
Midazolam—Dermatitis—Entecavir—hepatitis B	0.00313	0.00651	CcSEcCtD
Midazolam—Headache—Entecavir—hepatitis B	0.00311	0.00648	CcSEcCtD
Midazolam—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00308	0.00641	CcSEcCtD
Midazolam—Rash—Adefovir Dipivoxil—hepatitis B	0.00306	0.00636	CcSEcCtD
Midazolam—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00306	0.00635	CcSEcCtD
Midazolam—Headache—Adefovir Dipivoxil—hepatitis B	0.00304	0.00632	CcSEcCtD
Midazolam—Nausea—Entecavir—hepatitis B	0.00295	0.00614	CcSEcCtD
Midazolam—Asthenia—Telbivudine—hepatitis B	0.00293	0.00609	CcSEcCtD
Midazolam—Immune system disorder—Lamivudine—hepatitis B	0.00293	0.00609	CcSEcCtD
Midazolam—Mediastinal disorder—Lamivudine—hepatitis B	0.00292	0.00607	CcSEcCtD
Midazolam—Chills—Lamivudine—hepatitis B	0.00291	0.00605	CcSEcCtD
Midazolam—CYP3A5—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00289	0.0202	CbGpPWpGaD
Midazolam—Pruritus—Telbivudine—hepatitis B	0.00289	0.00601	CcSEcCtD
Midazolam—CYP4B1—Arachidonic acid metabolism—GGT1—hepatitis B	0.00289	0.0202	CbGpPWpGaD
Midazolam—Nausea—Adefovir Dipivoxil—hepatitis B	0.00288	0.00599	CcSEcCtD
Midazolam—Erythema—Lamivudine—hepatitis B	0.00282	0.00587	CcSEcCtD
Midazolam—CYP2B6—CYP2E1 reactions—CYP2A6—hepatitis B	0.00278	0.0194	CbGpPWpGaD
Midazolam—Tension—Lamivudine—hepatitis B	0.00277	0.00576	CcSEcCtD
Midazolam—Nervousness—Lamivudine—hepatitis B	0.00274	0.0057	CcSEcCtD
Midazolam—UGT1A4—blood plasma—hepatitis B	0.00272	0.244	CbGeAlD
Midazolam—CYP2E1—CYP2E1 reactions—CYP2A6—hepatitis B	0.00272	0.019	CbGpPWpGaD
Midazolam—Dizziness—Telbivudine—hepatitis B	0.0027	0.00562	CcSEcCtD
Midazolam—Tremor—Lamivudine—hepatitis B	0.00264	0.0055	CcSEcCtD
Midazolam—Vomiting—Telbivudine—hepatitis B	0.0026	0.0054	CcSEcCtD
Midazolam—CYP4B1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00259	0.0181	CbGpPWpGaD
Midazolam—Rash—Telbivudine—hepatitis B	0.00258	0.00536	CcSEcCtD
Midazolam—Dermatitis—Telbivudine—hepatitis B	0.00257	0.00535	CcSEcCtD
Midazolam—Headache—Telbivudine—hepatitis B	0.00256	0.00532	CcSEcCtD
Midazolam—Vertigo—Lamivudine—hepatitis B	0.00253	0.00527	CcSEcCtD
Midazolam—Syncope—Lamivudine—hepatitis B	0.00253	0.00526	CcSEcCtD
Midazolam—Cough—Lamivudine—hepatitis B	0.00246	0.00512	CcSEcCtD
Midazolam—UGT1A4—Phase II conjugation—GGT2—hepatitis B	0.00243	0.017	CbGpPWpGaD
Midazolam—Nausea—Telbivudine—hepatitis B	0.00243	0.00505	CcSEcCtD
Midazolam—Anxiety—Lamivudine—hepatitis B	0.00239	0.00498	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00238	0.00496	CcSEcCtD
Midazolam—Dry mouth—Lamivudine—hepatitis B	0.00235	0.00488	CcSEcCtD
Midazolam—CYP4B1—Metapathway biotransformation—AKR1B1—hepatitis B	0.00234	0.0164	CbGpPWpGaD
Midazolam—CYP3A7—Xenobiotics—CYP2A6—hepatitis B	0.00233	0.0163	CbGpPWpGaD
Midazolam—Confusional state—Lamivudine—hepatitis B	0.00232	0.00483	CcSEcCtD
Midazolam—Anaphylactic shock—Lamivudine—hepatitis B	0.0023	0.00479	CcSEcCtD
Midazolam—CYP4B1—Biological oxidations—GGT2—hepatitis B	0.00227	0.0159	CbGpPWpGaD
Midazolam—Shock—Lamivudine—hepatitis B	0.00226	0.00471	CcSEcCtD
Midazolam—Nervous system disorder—Lamivudine—hepatitis B	0.00226	0.00469	CcSEcCtD
Midazolam—Skin disorder—Lamivudine—hepatitis B	0.00224	0.00465	CcSEcCtD
Midazolam—Hypotension—Lamivudine—hepatitis B	0.00215	0.00447	CcSEcCtD
Midazolam—Paraesthesia—Lamivudine—hepatitis B	0.00207	0.0043	CcSEcCtD
Midazolam—Dyspnoea—Lamivudine—hepatitis B	0.00205	0.00427	CcSEcCtD
Midazolam—Somnolence—Lamivudine—hepatitis B	0.00205	0.00426	CcSEcCtD
Midazolam—Dyspepsia—Lamivudine—hepatitis B	0.00203	0.00421	CcSEcCtD
Midazolam—CYP2E1—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00202	0.0141	CbGpPWpGaD
Midazolam—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00199	0.00413	CcSEcCtD
Midazolam—Fatigue—Lamivudine—hepatitis B	0.00198	0.00413	CcSEcCtD
Midazolam—Pain—Lamivudine—hepatitis B	0.00197	0.00409	CcSEcCtD
Midazolam—Constipation—Lamivudine—hepatitis B	0.00197	0.00409	CcSEcCtD
Midazolam—Feeling abnormal—Lamivudine—hepatitis B	0.0019	0.00394	CcSEcCtD
Midazolam—Urticaria—Lamivudine—hepatitis B	0.00183	0.0038	CcSEcCtD
Midazolam—Flunitrazepam—CYP2A6—hepatitis B	0.00173	0.319	CrCbGaD
Midazolam—CYP2B6—Xenobiotics—CYP2A6—hepatitis B	0.00172	0.012	CbGpPWpGaD
Midazolam—Hypersensitivity—Lamivudine—hepatitis B	0.0017	0.00353	CcSEcCtD
Midazolam—CYP2E1—Xenobiotics—CYP2A6—hepatitis B	0.00169	0.0118	CbGpPWpGaD
Midazolam—CYP3A5—Xenobiotics—CYP2A6—hepatitis B	0.00168	0.0118	CbGpPWpGaD
Midazolam—Asthenia—Lamivudine—hepatitis B	0.00165	0.00343	CcSEcCtD
Midazolam—Pruritus—Lamivudine—hepatitis B	0.00163	0.00339	CcSEcCtD
Midazolam—CYP2E1—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00162	0.0113	CbGpPWpGaD
Midazolam—UGT1A4—NRF2 pathway—GGT2—hepatitis B	0.00162	0.0113	CbGpPWpGaD
Midazolam—CYP3A5—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00162	0.0113	CbGpPWpGaD
Midazolam—Dizziness—Lamivudine—hepatitis B	0.00152	0.00317	CcSEcCtD
Midazolam—Vomiting—Lamivudine—hepatitis B	0.00146	0.00304	CcSEcCtD
Midazolam—UGT1A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.00146	0.0102	CbGpPWpGaD
Midazolam—Rash—Lamivudine—hepatitis B	0.00145	0.00302	CcSEcCtD
Midazolam—Dermatitis—Lamivudine—hepatitis B	0.00145	0.00302	CcSEcCtD
Midazolam—Headache—Lamivudine—hepatitis B	0.00144	0.003	CcSEcCtD
Midazolam—UGT1A4—Biological oxidations—GGT2—hepatitis B	0.00142	0.00994	CbGpPWpGaD
Midazolam—Flurazepam—CYP2A6—hepatitis B	0.00139	0.256	CrCbGaD
Midazolam—CYP4B1—Biological oxidations—CYP2A6—hepatitis B	0.00138	0.00963	CbGpPWpGaD
Midazolam—CYP3A5—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00137	0.00957	CbGpPWpGaD
Midazolam—Nausea—Lamivudine—hepatitis B	0.00137	0.00284	CcSEcCtD
Midazolam—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00134	0.0094	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—KCNH1—hepatitis B	0.00132	0.00923	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—KCNH1—hepatitis B	0.00126	0.00881	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—KCNH1—hepatitis B	0.00126	0.00881	CbGpPWpGaD
Midazolam—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00125	0.00874	CbGpPWpGaD
Midazolam—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00118	0.00826	CbGpPWpGaD
Midazolam—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00116	0.00808	CbGpPWpGaD
Midazolam—UGT1A4—Phase II conjugation—GGT1—hepatitis B	0.00115	0.00804	CbGpPWpGaD
Midazolam—CYP4B1—Biological oxidations—GGT1—hepatitis B	0.00108	0.00752	CbGpPWpGaD
Midazolam—Ketazolam—ALB—hepatitis B	0.00104	0.192	CrCbGaD
Midazolam—GABRG3—Neuronal System—KCNH1—hepatitis B	0.00104	0.00725	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—KCNH1—hepatitis B	0.00102	0.00715	CbGpPWpGaD
Midazolam—UGT1A4—blood—hepatitis B	0.000998	0.0894	CbGeAlD
Midazolam—UGT1A4—NRF2 pathway—CYP2A6—hepatitis B	0.000982	0.00687	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—KCNH1—hepatitis B	0.000967	0.00676	CbGpPWpGaD
Midazolam—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000966	0.00676	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—KCNH1—hepatitis B	0.000955	0.00668	CbGpPWpGaD
Midazolam—CYP3A7—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000954	0.00667	CbGpPWpGaD
Midazolam—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000938	0.00656	CbGpPWpGaD
Midazolam—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.000935	0.00654	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00091	0.00637	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—KCNH1—hepatitis B	0.000873	0.00611	CbGpPWpGaD
Midazolam—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000872	0.00609	CbGpPWpGaD
Midazolam—UGT1A4—Biological oxidations—CYP2A6—hepatitis B	0.000862	0.00602	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—KCNH1—hepatitis B	0.000848	0.00593	CbGpPWpGaD
Midazolam—Clonazepam—ALB—hepatitis B	0.00084	0.155	CrCbGaD
Midazolam—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000833	0.00583	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—KCNH1—hepatitis B	0.000833	0.00583	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—KCNH1—hepatitis B	0.000819	0.00572	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—KCNH1—hepatitis B	0.000813	0.00569	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.000805	0.00563	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—KCNH1—hepatitis B	0.000799	0.00559	CbGpPWpGaD
Midazolam—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000783	0.00548	CbGpPWpGaD
Midazolam—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000782	0.00547	CbGpPWpGaD
Midazolam—UGT1A4—liver—hepatitis B	0.00078	0.0699	CbGeAlD
Midazolam—UGT1A4—NRF2 pathway—GGT1—hepatitis B	0.000767	0.00536	CbGpPWpGaD
Midazolam—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000752	0.00526	CbGpPWpGaD
Midazolam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000715	0.005	CbGpPWpGaD
Midazolam—CYP3A7—Metapathway biotransformation—AKR1B1—hepatitis B	0.000707	0.00494	CbGpPWpGaD
Midazolam—CYP2B6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000705	0.00493	CbGpPWpGaD
Midazolam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.0007	0.00489	CbGpPWpGaD
Midazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000699	0.00488	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—KCNH1—hepatitis B	0.000698	0.00488	CbGpPWpGaD
Midazolam—CYP2E1—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000691	0.00483	CbGpPWpGaD
Midazolam—CYP3A5—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000689	0.00482	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—GGT2—hepatitis B	0.000687	0.0048	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—ALPL—hepatitis B	0.000685	0.00479	CbGpPWpGaD
Midazolam—UGT1A4—Biological oxidations—GGT1—hepatitis B	0.000673	0.0047	CbGpPWpGaD
Midazolam—CYP3A5—blood plasma—hepatitis B	0.000668	0.0599	CbGeAlD
Midazolam—CYP2B6—blood plasma—hepatitis B	0.000664	0.0595	CbGeAlD
Midazolam—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.00065	0.00454	CbGpPWpGaD
Midazolam—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000636	0.00445	CbGpPWpGaD
Midazolam—CYP2E1—blood plasma—hepatitis B	0.000623	0.0558	CbGeAlD
Midazolam—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000607	0.00424	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—KCNH1—hepatitis B	0.000597	0.00418	CbGpPWpGaD
Midazolam—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000579	0.00405	CbGpPWpGaD
Midazolam—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000567	0.00397	CbGpPWpGaD
Midazolam—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000566	0.00396	CbGpPWpGaD
Midazolam—CYP3A7—liver—hepatitis B	0.000544	0.0487	CbGeAlD
Midazolam—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000537	0.00375	CbGpPWpGaD
Midazolam—CYP2B6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000523	0.00365	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000519	0.00363	CbGpPWpGaD
Midazolam—CYP2E1—Metapathway biotransformation—AKR1B1—hepatitis B	0.000512	0.00358	CbGpPWpGaD
Midazolam—CYP3A5—Metapathway biotransformation—AKR1B1—hepatitis B	0.000511	0.00357	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—GGT2—hepatitis B	0.000508	0.00355	CbGpPWpGaD
Midazolam—CYP3A4—blood plasma—hepatitis B	0.000501	0.0449	CbGeAlD
Midazolam—CYP2E1—Biological oxidations—GGT2—hepatitis B	0.000498	0.00348	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—GGT2—hepatitis B	0.000497	0.00347	CbGpPWpGaD
Midazolam—CYP3A7-CYP3A51P—liver—hepatitis B	0.000462	0.0414	CbGeAlD
Midazolam—Diazepam—ALB—hepatitis B	0.00043	0.0792	CrCbGaD
Midazolam—CYP3A7—Biological oxidations—CYP2A6—hepatitis B	0.000416	0.00291	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000413	0.00289	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—AKR1B1—hepatitis B	0.000405	0.00284	CbGpPWpGaD
Midazolam—SLC22A1—blood—hepatitis B	0.000403	0.0361	CbGeAlD
Midazolam—CYP4B1—Metabolism—GGT2—hepatitis B	0.000389	0.00272	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.00037	0.00259	CbGpPWpGaD
Midazolam—ABCB1—blood plasma—hepatitis B	0.000355	0.0318	CbGeAlD
Midazolam—CYP3A7—Biological oxidations—GGT1—hepatitis B	0.000325	0.00227	CbGpPWpGaD
Midazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000325	0.00227	CbGpPWpGaD
Midazolam—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00032	0.00224	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000315	0.0022	CbGpPWpGaD
Midazolam—SLC22A1—liver—hepatitis B	0.000315	0.0283	CbGeAlD
Midazolam—CYP2B6—Biological oxidations—CYP2A6—hepatitis B	0.000308	0.00215	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—CYP2A6—hepatitis B	0.000301	0.00211	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—CYP2A6—hepatitis B	0.000301	0.0021	CbGpPWpGaD
Midazolam—GABRB3—liver—hepatitis B	0.000281	0.0251	CbGeAlD
Midazolam—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000273	0.00191	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000273	0.00191	CbGpPWpGaD
Midazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000263	0.00184	CbGpPWpGaD
Midazolam—UGT1A4—NRF2 pathway—TGFB1—hepatitis B	0.000258	0.0018	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—AKR1B1—hepatitis B	0.000254	0.00177	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.000253	0.00177	CbGpPWpGaD
Midazolam—CYP3A5—blood—hepatitis B	0.000245	0.0219	CbGeAlD
Midazolam—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000244	0.00171	CbGpPWpGaD
Midazolam—CYP2B6—blood—hepatitis B	0.000243	0.0218	CbGeAlD
Midazolam—UGT1A4—Metabolism—GGT2—hepatitis B	0.000243	0.0017	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000241	0.00169	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—GGT1—hepatitis B	0.00024	0.00168	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.00024	0.00168	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000237	0.00166	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CYP2A6—hepatitis B	0.000236	0.00165	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—GGT1—hepatitis B	0.000235	0.00165	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—GGT1—hepatitis B	0.000235	0.00164	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000231	0.00161	CbGpPWpGaD
Midazolam—CYP2E1—blood—hepatitis B	0.000228	0.0205	CbGeAlD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000222	0.00155	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.00022	0.00154	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000219	0.00153	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GOT2—hepatitis B	0.000213	0.00149	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—CTNNB1—hepatitis B	0.000198	0.00138	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—NFKB1—hepatitis B	0.000192	0.00134	CbGpPWpGaD
Midazolam—CYP3A5—liver—hepatitis B	0.000191	0.0172	CbGeAlD
Midazolam—CYP2B6—liver—hepatitis B	0.00019	0.017	CbGeAlD
Midazolam—CYP4B1—Metabolism—GOT1—hepatitis B	0.000184	0.00129	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GGT1—hepatitis B	0.000184	0.00129	CbGpPWpGaD
Midazolam—CYP3A4—blood—hepatitis B	0.000184	0.0165	CbGeAlD
Midazolam—CYP2E1—liver—hepatitis B	0.000179	0.016	CbGeAlD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000168	0.00117	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IFNG—hepatitis B	0.00016	0.00112	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000159	0.00111	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000154	0.00108	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP2A6—hepatitis B	0.000147	0.00103	CbGpPWpGaD
Midazolam—CYP3A4—liver—hepatitis B	0.000144	0.0129	CbGeAlD
Midazolam—ABCB1—Allograft Rejection—IL2—hepatitis B	0.000142	0.000996	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.00014	0.000978	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GOT2—hepatitis B	0.000133	0.000932	CbGpPWpGaD
Midazolam—ABCB1—blood—hepatitis B	0.00013	0.0117	CbGeAlD
Midazolam—GABRR1—Transmembrane transport of small molecules—ALB—hepatitis B	0.00013	0.000908	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000125	0.000874	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—ALB—hepatitis B	0.000124	0.000866	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—ALB—hepatitis B	0.000124	0.000866	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AKR1B1—hepatitis B	0.000123	0.000857	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000121	0.000843	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—TNF—hepatitis B	0.00012	0.000839	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GGT2—hepatitis B	0.000117	0.000821	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—ALB—hepatitis B	0.000116	0.000808	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GOT1—hepatitis B	0.000115	0.000804	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GGT1—hepatitis B	0.000115	0.000804	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AKR1B1—hepatitis B	0.000114	0.000797	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—TGFB1—hepatitis B	0.000111	0.000777	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GGT2—hepatitis B	0.000109	0.000764	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000109	0.000763	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—TNF—hepatitis B	0.000104	0.000725	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—ALB—hepatitis B	0.000102	0.000713	CbGpPWpGaD
Midazolam—ABCB1—liver—hepatitis B	0.000102	0.00911	CbGeAlD
Midazolam—GABRB1—Transmembrane transport of small molecules—ALB—hepatitis B	0.0001	0.000702	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—ALB—hepatitis B	9.78e-05	0.000684	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL6—hepatitis B	9.68e-05	0.000677	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—ALB—hepatitis B	9.5e-05	0.000665	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—ALB—hepatitis B	9.38e-05	0.000656	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKR1B1—hepatitis B	9.06e-05	0.000634	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKR1B1—hepatitis B	8.87e-05	0.000621	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKR1B1—hepatitis B	8.86e-05	0.000619	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GGT2—hepatitis B	8.69e-05	0.000607	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—ALB—hepatitis B	8.58e-05	0.0006	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GGT2—hepatitis B	8.51e-05	0.000595	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GGT2—hepatitis B	8.49e-05	0.000594	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—ALB—hepatitis B	8.34e-05	0.000583	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—ALB—hepatitis B	8.19e-05	0.000573	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—ALB—hepatitis B	8.05e-05	0.000563	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—ALB—hepatitis B	7.99e-05	0.000559	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—ALB—hepatitis B	7.85e-05	0.000549	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PTEN—hepatitis B	7.46e-05	0.000522	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP2A6—hepatitis B	7.12e-05	0.000498	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—ALB—hepatitis B	6.86e-05	0.00048	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	6.79e-05	0.000474	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKR1B1—hepatitis B	6.68e-05	0.000467	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	6.63e-05	0.000463	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP2A6—hepatitis B	6.62e-05	0.000463	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	6.61e-05	0.000462	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	6.58e-05	0.00046	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GOT2—hepatitis B	6.44e-05	0.00045	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GGT2—hepatitis B	6.41e-05	0.000448	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ALB—hepatitis B	6.12e-05	0.000428	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GOT2—hepatitis B	5.99e-05	0.000419	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ALB—hepatitis B	5.87e-05	0.000411	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GGT1—hepatitis B	5.56e-05	0.000388	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GOT1—hepatitis B	5.56e-05	0.000388	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	5.48e-05	0.000383	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP2A6—hepatitis B	5.26e-05	0.000368	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GOT1—hepatitis B	5.17e-05	0.000362	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GGT1—hepatitis B	5.17e-05	0.000362	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP2A6—hepatitis B	5.15e-05	0.00036	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP2A6—hepatitis B	5.14e-05	0.00036	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	5.12e-05	0.000358	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GOT2—hepatitis B	4.76e-05	0.000333	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTEN—hepatitis B	4.67e-05	0.000326	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GOT2—hepatitis B	4.66e-05	0.000326	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GOT2—hepatitis B	4.65e-05	0.000325	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	4.51e-05	0.000316	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKR1B1—hepatitis B	4.12e-05	0.000288	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GGT1—hepatitis B	4.11e-05	0.000287	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GOT1—hepatitis B	4.11e-05	0.000287	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GGT1—hepatitis B	4.02e-05	0.000281	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GOT1—hepatitis B	4.02e-05	0.000281	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GGT1—hepatitis B	4.02e-05	0.000281	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GOT1—hepatitis B	4.02e-05	0.000281	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GGT2—hepatitis B	3.95e-05	0.000276	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP2A6—hepatitis B	3.88e-05	0.000271	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GOT2—hepatitis B	3.51e-05	0.000245	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	3.44e-05	0.000241	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GOT1—hepatitis B	3.03e-05	0.000212	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GGT1—hepatitis B	3.03e-05	0.000212	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ALB—hepatitis B	2.96e-05	0.000207	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALB—hepatitis B	2.75e-05	0.000192	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP2A6—hepatitis B	2.39e-05	0.000167	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTEN—hepatitis B	2.25e-05	0.000158	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALB—hepatitis B	2.19e-05	0.000153	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GOT2—hepatitis B	2.16e-05	0.000151	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALB—hepatitis B	2.14e-05	0.00015	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALB—hepatitis B	2.14e-05	0.000149	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTEN—hepatitis B	2.1e-05	0.000147	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GOT1—hepatitis B	1.87e-05	0.000131	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GGT1—hepatitis B	1.87e-05	0.000131	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTEN—hepatitis B	1.67e-05	0.000117	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTEN—hepatitis B	1.63e-05	0.000114	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTEN—hepatitis B	1.63e-05	0.000114	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALB—hepatitis B	1.61e-05	0.000113	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTEN—hepatitis B	1.23e-05	8.6e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALB—hepatitis B	9.93e-06	6.94e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTEN—hepatitis B	7.58e-06	5.3e-05	CbGpPWpGaD
